The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2013

Filed:

May. 03, 2006
Applicants:

Dario Neri, Buchs, CH;

Verena Gafner, Bern, CH;

Cornelia Halin, Zurich, CH;

Inventors:

Dario Neri, Buchs, CH;

Verena Gafner, Bern, CH;

Cornelia Halin, Zurich, CH;

Assignee:

Philogen S.p.A., Siena, IT;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 16/46 (2006.01); C07K 14/54 (2006.01); C07H 21/04 (2006.01); C12N 5/16 (2006.01); C12N 1/21 (2006.01); C12N 15/63 (2006.01); C12N 15/24 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Conjugate for targeting therapeutic or diagnostic agent or drug to cells or tissues in a body, e.g. areas of neoplastic growth or angiogenesis. Use of conjugate for in vivo diagnosis or therapy e.g. inhibiting tumor growth or metastasis, inhibiting angiogenesis and/or treating cancer. Conjugate comprises therapeutic or diagnostic agent as oligomeric protein e.g. heterodimeric protein, wherein first and second subunits of protein are each conjugated to a specific binding member e.g. an antibody fragment such as scFv. Subunits of oligomer may be conjugated to specific binding members as fusion proteins. Conjugate may comprise IL-12 heterodimer having two subunits, each subunit fused to scFv L19 or TN11 for targeting IL-12 to extracellular matrix components associated with neoplastic growth and angiogenesis.


Find Patent Forward Citations

Loading…